Abstract:Efficient therapies for breast cancer remain elusive because of the lack of strategies for targeted transport and receptor-mediated uptake of synthetic drug molecules by cancer cells. Conjugation of nanoparticles (NPs) with active targeting ligands enabling selective molecular recognition of antigens expressed on the surface of cancer cells is promising for localization and treatment of malignant cells. In this study, covalent attachment of synthetic estrogen 17α-ethynylestradiol on the silica (SiO2) shell of silica-gold NPs (SiO2@Au) was undertaken to improve the cancer-targeting ability of the nano-biotags. Chemical and structural analysis of the bioconjugates examined in solution (UV–vis and ξ-potential) and solid state (Fourier transform infrared spectroscopy, X-ray diffractometry, and transmission electron microscopy) confirmed the identity of the carrier particles and surface-bound ligands. The mesoporous silica shell served as a reservoir for anticancer drugs (doxorubicin and quercetin) and to facilitate covalent attachment of receptor molecules by click chemistry protocols. The chemoselective recognition between the nanoconjugates and cell membranes was successfully demonstrated by the accumulation of nanoprobes in the tumor tissue of mice with subcutaneous breast cancer, whereas healthy cells were unaffected. The drug release studies showed sustained release kinetics over several weeks. These findings elaborate the exceptional selectivity and potential of estrogen-coated nano-biolabels in efficient diagnosis and detection of breast cancer cells.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.langmuir.0c02820?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.langmuir.0c02820</a>.TG–DSC of chloroauric acid tetrahydrate; size distribution of the as-prepared Au nanorods and of the shell thickness of mSiO2@Au NPs; UV–vis spectra of quercetin, quercetin-loaded mSiO2@Au NPs and released oxidized quercetin derivate 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxybenzofuran-3(2H)-one; calibration curve of quercetin and doxorubicin determined via UV–vis; autofluorescence of MCF-7 breast cancer cells; flow cytometry measurements of E0771 cells, incubated with AF647/Diol-mSiO2@Au NPs; and flow cytometry measurements of control mice treated with PBS (<a class="ext-link" href="/doi/suppl/10.1021/acs.langmuir.0c02820/suppl_file/la0c02820_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

New Enhancement Spectrofluorimetric Determination of Anti‐Breast Cancer Drugs Palbociclib by Biogenic‐Synthesized Alumina/NiO Nanocomposite

Rapid microwave-assisted synthesis of nitrogen-doped carbon quantum dots as fluorescent nanosensors for the spectrofluorimetric determination of palbociclib: application for cellular imaging and selective probing in living cancer cells

Enhanced fluorescent detection of oxaliplatin via BSA@copper nanoclusters: a targeted approach for cancer drug monitoring

Blends of TiO2 nanoparticles and poly (N-isopropylacrylamide)-co-polystyrene nanofibers as a means to promote the biorecognition of an anticancer drug.

An Ultrasensitive Electrochemical Sensor Using Banana Peel Activated Carbon/NiFe2O4/MnCoFe-LDH Nanocomposites for Anticancer Drug Determination

Superior Electrochemical Sensor Application of Co3O4/C Heterostructure in Rapid Analysis of Anticancer Drug Palbociclib in Pharmaceutical Formulations and Biological Fluids

Copper(II)–mediated Sliver Nanoclusters As a Fluorescent Platform for Highly Sensitive Detection of Alendronate Sodium

Synthesis, characterization, and optimization of dual‐responsive PAMAM nanodendrimers for improved dispersive solid‐phase extraction of cancer agents from complex biological samples

Development and characterization of palbociclib-loaded PLGA nanobubbles for targeted cancer therapy

Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor

Investigation of green synchronous spectrofluorimetric approach for facile sensitive estimation of two co-administered anti-cancer drugs; curcumin and doxorubicin in their laboratory-prepared mixtures, human plasma, and urine

Advanced fluorescence-based determination of carboplatin, a potent anticancer agent, with tripeptide-functionalized copper nanoclusters

Targeted Delivery and Apoptosis Induction of CDK-4/6 inhibitor Loaded Folic Acid Decorated Lipid-Polymer Hybrid Nanoparticles in Breast Cancer cells

A highly sensitive first derivative synchronous spectrofluorimetric approach for the simultaneous analysis of the anti-breast cancer co-administered drugs, letrozole and tramadol in dosage forms and human plasma at nanogram levels

Receptor-Mediated In Vivo Targeting of Breast Cancer Cells with 17α-Ethynylestradiol-Conjugated Silica-Coated Gold Nanoparticles

Biogenic Synthesis of Ag NPs Adorned Gellan Gum Modified Fe3O4 NPs Towards the Catalytic Reduction of Nitroarenes and the Investigation of Anti-breast Cancer Potential

Fabrication of β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin inclusion complexes of Palbociclib: Physicochemical characterization, solubility enhancement, in -silico studies, in vitro assessment in MDA-MB-231 cell line

Designing of Polymeric Nanoparticles for Enhanced Breast Cancer Therapy: Combining Paclitaxel, Boric Acid and Tannic Acid for Controlled Drug Delivery

Synergic fabrication of folic acid-targeted hyperbranched polymer (HBP)-modified pH-response drug delivery system for the treatment of breast cancer

A new and powerful electrochemical sensing platform based on MWCNTs@Fe3O4@CuAl2O4 for the determination of the anticancer agent Alpelisib in bulk and biological fluids

Synthesis, Characterization, and In-Vitro Evaluation of Silibinin-loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effects on SW480 Colon Cancer Cells